Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Diacerein manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Greece

Clear all

2 products found

diacerein

Capsules 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Greece
Available for
Licensing with supply, Distribution only
Manufacturer #271
A pharmaceutical manufacturer based in the EU that is active in 30+ countries selling its products in Europe, Africa, the Middle East, and Asia for 50+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, nutraceuticals, infant nutrition, and cosmetics. Main therapeutic areas include dermatology, antibiotics, and oncology.

Manufacturer usually replies in 9 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is Diacerein?

Diacerein is from the anthraquinone class of medication. Diacerein medicine is used to treat joint diseases such as osteoarthritis (swelling and pain in the joints). Diacerein acts by reducing inflammation and cartilage destruction. Diacerein is also known as diacetylrhein.

Diacerein wholesalers and manufacturers:

Diacerein is known under many brand names; almost each Diacerein manufacturer has a specific brand name for their product. For example, we can enumerate Acebac, Durajoint, Cartiglow in India, Zondar in France, Diatrim by Trima Israel. Only some countries of the European Union (Austria, Czech Republic, France, Greece, Italy, Portugal, Slovakia, and Spain) and India have approved the Diacerein medical use to treat osteoarthritis. However, the United States has not yet authorized the use of Diacerein due to too severe side effects. There are around 147 Diacerein suppliers in China, 6 in the UK, 3 in the EU. Diacerein suppliers market it in the form of a 50 mg capsule.

Diacerein for sales:

In the US, for a 25 mg capsule, Diacerein costs about $35, and for a 50 mg capsule, it costs around $67. Some of the Diacerein suppliers are Henan Tianfu Chemicals Co Ltd, TCI Europe, Carbosynth. As Diacerein is a drug globally found but not approved in every country, on the internet, you can encounter fraudulent websites that will want to sell Diacerein with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid the time-consuming sourcing and you directly find qualified sellers of Diacerein that have been through quality control procedures to assure they were qualified partners. On the online platform, Diacerein is mostly available from the European Union, Egypt, India, and Israel. Thanks to the intuitive online marketplace, you will find Diacerein and many other drugs quickly and efficiently. Placing an order has never been easier than with Pipelinepharma. Let us connect you with Diacerein manufacturers and distributors.

How to use Diacerein?

To treat osteoarthritis, an adult patient should take a 50 mg capsule twice a day. Taking Diacerein medicine can cause some side effects. The most common ones are diarrhea, abdominal pain, pruritus, rash, eczéma. Be careful than due to severe diarrhea; health authorities have restricted the use of the drug, Diacerein is no longer recommended in patients aged 65 years and above. Diacerein should be administered with food. Diacerein capsules must be stored in the refrigerator.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation